دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Two small words: one large commitment
doi : 10.1016/S2215-0366(23)00340-1
Volume 10, Issue 11, November 2023, Page 817
Antipsychotic dose reduction: unclear benefits but certain risks
doi : 10.1016/S2215-0366(23)00308-5
Volume 10, Issue 11, November 2023, Pages 819-821
A lived experience perspective on the results of the RADAR trial
doi : 10.1016/S2215-0366(23)00266-3
Volume 10, Issue 11, November 2023, Page 830
Are brief admissions helpful for adolescents with borderline personality traits?
doi : 10.1016/S2215-0366(23)00294-8
Volume 10, Issue 11, November 2023, Pages 830-831
Are brief admissions helpful for adolescents with borderline personality traits? – Authors' reply
doi : 10.1016/S2215-0366(23)00336-X
Volume 10, Issue 11, November 2023, Page 831
Improving mental health care among patients with cancer in China
doi : 10.1016/S2215-0366(23)00297-3
Volume 10, Issue 11, November 2023, Pages 831-832
The ethical conundrums of disclosing mental illness at work in India
doi : 10.1016/S2215-0366(23)00333-4
Volume 10, Issue 11, November 2023, Page e28
Correction to Lancet Psychiatry 2023; 10: 848–59
doi : 10.1016/S2215-0366(23)00342-5
Volume 10, Issue 11, November 2023, Page e29
A psychiatrist returning to work after a severe mental illness
doi : 10.1016/S2215-0366(23)00296-1
Volume 10, Issue 11, November 2023, Pages 834-835
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses
doi : 10.1016/S2215-0366(23)00257-2
Volume 10, Issue 11, November 2023, Pages 836-847
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial
doi : 10.1016/S2215-0366(23)00258-4
Volume 10, Issue 11, November 2023, Pages 848-859
